ARCHIVES

QOL With Femara Comparable To Placebo, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

November 5, 1982

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

Response Oncology Sells Practice Back To Physicians.

March 2, 2001

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012